Sunday, October 18, 2026
ExploreSearch
Via News
MarketsIndex

S&P 500 Bullish Momentum: 1.48% Up Since The Last Session

ViaNews Editorial Team

January 7, 2021

S&P 500 Bullish Momentum: 1.48% Up Since The Last Session

S&P 500 is currently on bullish momentum. At 16:27 EST on Thursday, 7 January, S&P 500 is at $3,803.79, 1.48% up since the last session's close.

S&P 500 Range

S&P 500 is 2.657% up from its last session low of $3,705.34 and 0.549% up from its last session high of $3,783.04.

Over the last three sessions, S&P 500's higher value was $3,783.04 and the lower value was $3,662.71.

Over the last seven sessions, S&P 500's higher value was $3,783.04 and the lower value was $3,662.71.

Over the last month, S&P 500's higher value was $3,783.04 and the lower value was $3,633.40.

Regarding S&P 500's yearly highs and lows, it's 1.038% up from its 52-week low and 0.204% down from its 52-week high.

Categories

MarketsIndex

Tags

IndexWorld IndicesIndicesSPXS&P 500
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com